<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               14 CLINICAL STUDIES<BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     14.1 Non-Small Cell Lung Cancer (NSCLC) – TARCEVA Monotherapy Administered as Maintenance Treatment<BR>                     <BR>                        The efficacy and safety of TARCEVA as maintenance treatment of NSCLC were demonstrated in a randomized, double-blind, placebo-controlled trial conducted in 26 countries, in 889 patients with locally advanced or metastatic NSCLC whose disease did not progress during first line platinum-based chemotherapy. Patients were randomized 1:1 to receive TARCEVA 150 mg or placebo orally once daily (438 TARCEVA, 451 placebo) until disease progression or unacceptable toxicity. The primary objective of the study was to determine if the administration of TARCEVA after standard platinum-based chemotherapy in the treatment of NSCLC resulted in improved progression free survival (PFS) when compared with placebo, in all patients or in patients with EGFR immunohistochemistry (IHC) positive tumors.<BR>                        Demographic characteristics were balanced between the two treatment groups (Table 5). <BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="single" width="394.000" ID="id_e8f63d76-803d-4306-bbf2-981b321bbe38"><BR>                           <caption ID="id_0dd2810c-66c6-4f04-aed3-361b0bafb0ed">Table 5: Demographic and Disease Characteristics</caption><BR>                           <col width="51.8%"/><BR>                           <col width="11.9%"/><BR>                           <col width="11.9%"/><BR>                           <col width="12.2%"/><BR>                           <col width="12.2%"/><BR>                           <tbody><BR>                              <tr ID="id_b89ea7f2-df38-4d65-8fd7-e0c0a9cf9ecc"><BR>                                 <td align="left" valign="bottom" styleCode="Botrule Toprule Rrule Lrule"/><BR>                                 <td align="center" valign="bottom" colspan="2" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">TARCEVA<br/>N=438</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" colspan="2" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">PLACEBO<br/>N=451</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_d72baa75-b6ec-4133-906a-f7706bb80371"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Characteristics</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">N</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">(%)</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">N</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">(%)</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_db8fb2ff-c290-406b-ab09-63ddde007ba3"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Gender</content><BR>                                 </td><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_fbf2068b-e9e8-41db-917f-c278fca2fbe2"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Female</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">117&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(27%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">113&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(25%)</td><BR>                              </tr><BR>                              <tr ID="id_1a11fcea-3ffa-4cd7-8986-80ce34c34917"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Male</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">321&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(73%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">338&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(75%)</td><BR>                              </tr><BR>                              <tr ID="id_b585fdfa-de68-4abd-a623-68870afd4a6c"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Age (years)</content><BR>                                 </td><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_98e8d300-969f-459d-8cf1-bf181372c269"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#8805;65 Years</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">148&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(34%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">151&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(33%)</td><BR>                              </tr><BR>                              <tr ID="id_f446c001-9c0d-4ace-9d02-ee0779208176"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&lt; 65 Years</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">290&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(66%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">300&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(67%)</td><BR>                              </tr><BR>                              <tr ID="id_9da0df24-1536-4686-834d-d660a20a3593"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Stage of NSCLC </content><BR>                                 </td><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_e7807f10-6663-4742-9cd4-ee0ff160a91f"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Unresectable Stage IIIB</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">116&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(26%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">109&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(24%)</td><BR>                              </tr><BR>                              <tr ID="id_bacc4ceb-0d10-48b8-a5c2-6389c72e03f1"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Stage IV</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">322&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(74%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">342&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(76%)</td><BR>                              </tr><BR>                              <tr ID="id_d799bfd9-7352-4042-bd66-22c30aa7c559"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Race</content><BR>                                 </td><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_bb02afad-5d37-49fb-999d-f9fe86592bb2"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Caucasian</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">370&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(84%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">376&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(83%)</td><BR>                              </tr><BR>                              <tr ID="id_2a710d9a-4679-4515-958d-2f5a0cdc024b"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Black</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;&#160;&#160;3&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(&lt;1%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;&#160;&#160;1&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(&lt;1%)</td><BR>                              </tr><BR>                              <tr ID="id_3aca4c7e-e5c8-4ca2-a93f-f38f929eab62"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Asian</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;62&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(14%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;69&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(15%)</td><BR>                              </tr><BR>                              <tr ID="id_49082ed3-2afd-4dc5-a516-f0df8a32a629"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Other</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;&#160;&#160;3&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(&lt;1%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;&#160;&#160;5&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(1%)</td><BR>                              </tr><BR>                              <tr ID="id_8800815f-d56a-40c5-b80d-0d71b460db17"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">ECOG Performance Status at Baseline </content><BR>                                 </td><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_dc76c599-35b5-4360-a11d-7c89341a709d"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">135&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(31%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">145&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(32%)</td><BR>                              </tr><BR>                              <tr ID="id_de6bfc8e-0a3d-45ba-b592-a7f3cc60e1b8"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">303&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(69%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">306&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(68%)</td><BR>                              </tr><BR>                              <tr ID="id_c8645764-5b78-455d-86ad-c188306cbdc1"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">EGFR IHC</content><BR>                                 </td><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_a5d261a7-da73-40bb-b7d0-b3407813fce0"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Positive</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">308&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(70%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">313&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(69%)</td><BR>                              </tr><BR>                              <tr ID="id_545b7174-3604-4ba5-8517-abcd85c9523b"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Negative</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;62&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(14%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;59&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(13%)</td><BR>                              </tr><BR>                              <tr ID="id_e89c7a24-eea8-4d11-a03f-ab6c52551512"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Indeterminate</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;16&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(4%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;24&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(5%)</td><BR>                              </tr><BR>                              <tr ID="id_3c5375b5-5535-482f-8ae5-b89a464eb13c"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Missing</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;52&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(12%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;55&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(12%)</td><BR>                              </tr><BR>                              <tr ID="id_86721229-f609-4d41-8939-85ad1cfdbb9a"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Histology </content><BR>                                 </td><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_1b0eb0b9-475f-45a5-a8dc-2c79636c5013"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Squamous</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">166&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;(38%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">194&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(43%)</td><BR>                              </tr><BR>                              <tr ID="id_45259341-2c6a-4092-93cd-d47e5690bbeb"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Adenocarcinoma including Bronchioloaveolar</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">205&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(47%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">198&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(44%)</td><BR>                              </tr><BR>                              <tr ID="id_fde9a601-0a9e-455a-8dae-4f3767b11edd"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Large Cell</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;21&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(5%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;24&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(5%)</td><BR>                              </tr><BR>                              <tr ID="id_553ee2d4-3dd4-49d4-b528-893275f4a9f4"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Other</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;46&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(11%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;35&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(8%)</td><BR>                              </tr><BR>                              <tr ID="id_8d527564-a95f-44ef-97bd-03c4298c4163"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Smoking Status </content><BR>                                 </td><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_3fc24ce9-96d4-4962-97c2-749307dc12df"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Current Smoker</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">239&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(55%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">254&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(56%)</td><BR>                              </tr><BR>                              <tr ID="id_d933c38e-7c81-46f0-8c9c-cbc61a37ce2d"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Never Smoked</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;77&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(18%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&#160;&#160;75&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(17%)</td><BR>                              </tr><BR>                              <tr ID="id_561f7517-0341-4869-9f23-79eb438a1700"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160; &#160;Past Smoker</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">122&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(28%)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">122&#160;&#160;</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(27%)</td><BR>                              </tr><BR>                              <tr ID="id_52fbd8f5-141c-434d-a9cf-84206d1a8a98"><BR>                                 <td align="left" valign="top" colspan="5" styleCode="Lrule Botrule Rrule">Smoking status: Current smoker = smoker at time of randomization or stopped within 1 year prior to randomization.</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>Progression free survival (PFS) and overall survival (OS) were evaluated in the intent-to-treat (ITT) population. The results of the study are shown in Table 6.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="single" width="443.000" ID="id_2b4b4a39-118f-44f5-91f0-1d5116097c4c"><BR>                           <caption ID="id_d38c1aee-755f-4e5b-8d06-e8a41b99b582">Table 6: Efficacy Results: (ITT Population)</caption><BR>                           <col width="29.8%"/><BR>                           <col width="17.6%"/><BR>                           <col width="14.9%"/><BR>                           <col width="23.9%"/><BR>                           <col width="13.8%"/><BR>                           <tfoot ID="id_a036d975-e27a-4509-8d16-e72a8105e76d"><BR>                              <tr><BR>                                 <td align="left" valign="top" colspan="5" styleCode="Lrule Botrule Rrule">(1) Univariate Cox regression model<br/>(2) Unstratified log-rank test.</td><BR>                              </tr><BR>                           </tfoot><BR>                           <tbody><BR>                              <tr ID="id_b60a8268-a882-4005-90c3-7fd6f2f77094"><BR>                                 <td align="left" valign="top" styleCode="Lrule Toprule Rrule"/><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Median in Months (95% CI)</content><BR>                                 </td><BR>                                 <td align="center" valign="top" rowspan="2" styleCode="Botrule Rrule"><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Hazard Ratio (1)</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">(95% CI)</content><BR>                                 </td><BR>                                 <td align="center" valign="top" rowspan="2" styleCode="Botrule Rrule"><BR>                                    <paragraph><BR>                                       <content styleCode="bold">p-value (2)</content><BR>                                    </paragraph><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_e2994b2e-cd70-42c2-9172-dce788f9a8da"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <paragraph><BR>                                       <content styleCode="bold">TARCEVA 150 mg</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">N = 438</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Placebo</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">N=451</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_3f1d96c0-6964-477a-8fb4-8d3aebf8a776"><BR>                                 <td align="center" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Progression-Free Survival based on investigator&#8217;s assessment</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">2.8 (2.8, 3.1)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">2.6 (1.9, 2.7)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <paragraph>0.71 (0.62, 0.82)</paragraph><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">p &lt; 0.0001</td><BR>                              </tr><BR>                              <tr ID="id_bc40aaa1-9079-4f68-9507-2c20bc9251ea"><BR>                                 <td align="center" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Overall Survival</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Rrule">12.0 (10.6, 13.9)</td><BR>                                 <td align="center" valign="top" styleCode="Rrule">11.0 (9.9,12.1)</td><BR>                                 <td align="center" valign="top" styleCode="Rrule">0.81 (0.70, 0.95)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.0088</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>Figure 1 depicts the Kaplan Meier Curves for Overall Survival (ITT Population).<BR>                        <BR>                        <BR>                           Note: HR is from a univariate Cox regression model.<BR>                        The PFS and OS Hazard Ratios, respectively, in patients with EGFR IHC-positive tumors were 0.69 (95% CI: 0.58, 0.82) and 0.77 (95% CI: 0.64, 0.93). The PFS and OS Hazard Ratios in patients with IHC-negative tumors were 0.77 (95% CI: 0.51, 1.14) and 0.91 (95% CI: 0.59, 1.38), respectively.<BR>                        Patients with adenocarcinoma had an OS Hazard Ratio of 0.77 (95% CI: 0.61, 0.97) and patients with squamous histology had an OS Hazard Ratio of 0.86 (95% CI: 0.68, 1.10).<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     14.2 NSCLC – Second/Third Line Study<BR>                     <BR>                        The efficacy and safety of single-agent TARCEVA was assessed in a randomized, double blind, placebo-controlled trial in 731 patients with locally advanced or metastatic NSCLC after failure of at least one chemotherapy regimen. Patients were randomized 2:1 to receive TARCEVA 150 mg or placebo (488 Tarceva, 243 placebo) orally once daily until disease progression or unacceptable toxicity. Study endpoints included overall survival, response rate, and progression-free survival (PFS). Duration of response was also examined. The primary endpoint was survival. The study was conducted in 17 countries. <BR>                        <BR>                           Table 7 summarizes the demographic and disease characteristics of the study population. Demographic characteristics were well balanced between the two treatment groups. About two-thirds of the patients were male. Approximately one-fourth had a baseline ECOG performance status (PS) of 2, and 9% had a baseline ECOG PS of 3. Fifty percent of the patients had received only one prior regimen of chemotherapy. About three quarters of these patients were known to have smoked at some time.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="single" width="340.000" ID="id_d1c0e5c7-5957-4684-a082-eab97f994bcb"><BR>                           <caption ID="id_12b4c696-08fd-4bc4-b4c3-7caf2f01c57d">Table 7: Demographic and Disease Characteristics</caption><BR>                           <col width="42.1%"/><BR>                           <col width="14.1%"/><BR>                           <col width="14.1%"/><BR>                           <col width="14.1%"/><BR>                           <col width="15.6%"/><BR>                           <tfoot ID="id_b5c698bb-7c70-4d13-bc0c-37875d9642f9"><BR>                              <tr><BR>                                 <td align="left" valign="top" colspan="5" styleCode="Lrule Botrule Rrule">* Stratification factor as documented at baseline; distribution differs slightly from values reported at time of randomization.</td><BR>                              </tr><BR>                           </tfoot><BR>                           <tbody><BR>                              <tr ID="id_95b6fb97-a697-424c-8f53-dda02400c406"><BR>                                 <td align="left" valign="top" styleCode="Botrule Toprule Rrule Lrule"/><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">TARCEVA<br/>(N = 488)</content><BR>                                 </td><BR>                                 <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Placebo<br/>(N = 243)</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_a51dd015-026f-456d-a604-8d0c25a997e2"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Characteristics</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">n</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">(%)</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">n</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">(%)</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_1b509199-61a8-4d99-9f8c-87d7eb594519"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Gender</content><BR>                                 </td><BR>                                 <td align="right" valign="top" styleCode="Botrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_9b4a4bff-9e9c-4b11-a384-f7eaebc40fe0"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Female</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">173</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(35)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">83</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(34)</td><BR>                              </tr><BR>                              <tr ID="id_196f36c0-3950-4485-956f-176098820050"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Male</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">315</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(65)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">160</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(66)</td><BR>                              </tr><BR>                              <tr ID="id_bc7fef16-d7a1-414f-833f-dacebe3410eb"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Age (years)</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_6035e4f4-8da9-4087-a505-69d2da3d22ed"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;&lt; 65</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">299</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(61)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">153</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(63)</td><BR>                              </tr><BR>                              <tr ID="id_c95cfeb2-ce74-48ab-b22f-74b51ba46b74"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;&#8805; 65</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">189</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(39)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">90</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(37)</td><BR>                              </tr><BR>                              <tr ID="id_655b85f1-d761-4ae9-995e-468d7900a8c4"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Race</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_a007cc13-ae10-46c9-83fb-b5ea653450d6"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Caucasian</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">379</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(78)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">188</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(77)</td><BR>                              </tr><BR>                              <tr ID="id_ad327fda-4967-4a6d-8b5b-d7dfa1a2ae4a"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Black</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">18</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(4)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">12</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(5)</td><BR>                              </tr><BR>                              <tr ID="id_23ee96b6-a2a2-4da3-981f-e47dd92ac9ef"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Asian</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">63</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(13)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">28</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(12)</td><BR>                              </tr><BR>                              <tr ID="id_797eff29-5504-42a1-a2c8-1c29724fba32"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Other</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">28</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(6)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">15</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(6)</td><BR>                              </tr><BR>                              <tr ID="id_367a4dbb-c4cd-4204-9229-fa2aecd99edb"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">ECOG Performance Status at Baseline*</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_20c56316-7929-45ad-b2bc-68197ce658fd"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">64</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(13)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">34</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(14)</td><BR>                              </tr><BR>                              <tr ID="id_814a9eb9-f5ba-4d5f-a987-1bcd0442df1f"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">256</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(52)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">132</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(54)</td><BR>                              </tr><BR>                              <tr ID="id_13235813-c1de-4601-83c6-8a5e2a998c9e"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">126</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(26)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">56</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(23)</td><BR>                              </tr><BR>                              <tr ID="id_bbff3649-d7b0-43af-a05c-db4140980149"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;3</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">42</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(9)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">21</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(9)</td><BR>                              </tr><BR>                              <tr ID="id_002000cb-4f87-4e6e-99ff-64ec25b1b5dc"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Weight Loss in Previous 6 Months</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_efe929ec-4311-4ac1-b29b-578e00c58ee9"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;&lt; 5%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">320</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(66)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">166</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(68)</td><BR>                              </tr><BR>                              <tr ID="id_be47ba95-8289-44a9-aa0c-34c8b0f4f576"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;5 &#8211; 10%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">96</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(20)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">36</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(15)</td><BR>                              </tr><BR>                              <tr ID="id_3ea8ca69-d563-4c01-848a-bd6822b5f02f"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;&gt; 10%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">52</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(11)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">29</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(12)</td><BR>                              </tr><BR>                              <tr ID="id_522a77d5-44ed-45f3-be88-759ea0c33a7e"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Unknown</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">20</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(4)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">12</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(5)</td><BR>                              </tr><BR>                              <tr ID="id_7ad652ed-def3-4989-a495-a95879df42ff"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Smoking History</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_7a5e8c32-59dc-426f-a4c8-029ebc37afd0"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Never Smoked</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">104</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(21)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">42</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(17)</td><BR>                              </tr><BR>                              <tr ID="id_13df4ce7-894f-4808-983e-a58754e4f782"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Current or Ex-smoker</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">358</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(73)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">187</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(77)</td><BR>                              </tr><BR>                              <tr ID="id_e7e4b21d-e509-4272-a106-0f1e74e42171"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Unknown</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">26</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(5)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">14</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(6)</td><BR>                              </tr><BR>                              <tr ID="id_00900750-2bc7-4713-ab95-cc2a90716dd4"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Histological Classification</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_870ad78e-4e8a-4ac3-919b-07b3bd095fca"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Adenocarcinoma</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">246</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(50)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">119</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(49)</td><BR>                              </tr><BR>                              <tr ID="id_79b7342e-f543-4088-819d-b8c8ac392b1b"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Squamous</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">144</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(30)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">78</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(32)</td><BR>                              </tr><BR>                              <tr ID="id_0cfdec24-5b81-4420-8c2a-558ff9bb72a1"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Undifferentiated Large Cell</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">41</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(8)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">23</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(9)</td><BR>                              </tr><BR>                              <tr ID="id_820addd8-f36e-4118-a393-a5ad903784f1"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Mixed Non-Small Cell</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">11</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(2)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(&lt;1)</td><BR>                              </tr><BR>                              <tr ID="id_c5382d44-a3aa-4c3b-8246-1b6fb6d3c8b3"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Other</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">46</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(9)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">21</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(9)</td><BR>                              </tr><BR>                              <tr ID="id_9b4737c9-caa6-4067-9e7f-d21f26ed672c"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Time from Initial Diagnosis to Randomization (Months)</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_3fc785a5-5704-49d9-acb8-916d0e1c2d8d"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;&lt; 6</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">63</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(13)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">34</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(14)</td><BR>                              </tr><BR>                              <tr ID="id_e3566615-3dda-4c90-a051-1079ceb4d1b9"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;6 &#8211; 12</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">157</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(32)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">85</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(35)</td><BR>                              </tr><BR>                              <tr ID="id_c832b4e7-732e-41b1-a59d-c429ce898889"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;&gt; 12</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">268</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(55)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">124</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(51)</td><BR>                              </tr><BR>                              <tr ID="id_0dadc59a-1ab9-4159-8b06-558e08634621"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Best Response to Prior Therapy at Baseline*</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_9947839c-4c5f-47d3-b77f-3278c3b9b438"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;CR/PR</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">196</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(40)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">96</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(40)</td><BR>                              </tr><BR>                              <tr ID="id_32b103c5-b1fd-461e-9c04-477bb89a4ac6"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;PD</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">101</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(21)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">51</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(21)</td><BR>                              </tr><BR>                              <tr ID="id_0823cb15-9f57-459f-b9bf-e23a28c7bd37"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;SD</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">191</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(39)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">96</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(40)</td><BR>                              </tr><BR>                              <tr ID="id_b31af485-c9f6-4a1c-82a5-24751b314500"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Number of Prior Regimens at Baseline*</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_d77d8d0f-07a1-4323-bc38-fed3bc86f2e0"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">243</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(50)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">121</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(50)</td><BR>                              </tr><BR>                              <tr ID="id_7c1d2ed8-b86d-4571-b8e5-81bb306a8043"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">238</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(49)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">119</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(49)</td><BR>                              </tr><BR>                              <tr ID="id_9489d7aa-8950-4798-a5c3-edd64314ec8c"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;3</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">7</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(1)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">3</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(1)</td><BR>                              </tr><BR>                              <tr ID="id_a8da949f-8603-44bc-b66a-e1429695a25a"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Exposure to Prior Platinum at Baseline*</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_5d647a43-3de3-4cd9-8555-53f0c3f027a0"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Yes</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">454</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(93)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">224</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(92)</td><BR>                              </tr><BR>                              <tr ID="id_0c874769-dd2e-4cb9-b1f8-100b6753f8f3"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;No</td><BR>                                 <td align="center" valign="top" styleCode="Rrule">34</td><BR>                                 <td align="center" valign="top" styleCode="Rrule">(7)</td><BR>                                 <td align="center" valign="top" styleCode="Rrule">19</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">(8)</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>The results of the study are shown in Table 8.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="single" width="395.000" ID="id_7297fcd8-693e-4356-b472-2514b2fd410f"><BR>                           <caption ID="id_2cf7bd8d-e2dc-460c-9e25-709c652c2d72">Table 8: Efficacy Results</caption><BR>                           <col width="17.7%"/><BR>                           <col width="17.0%"/><BR>                           <col width="15.2%"/><BR>                           <col width="13.9%"/><BR>                           <col width="16.7%"/><BR>                           <col width="19.5%"/><BR>                           <tfoot ID="id_6f72df16-f52d-4e11-ae54-eb81ec1fb2f4"><BR>                              <tr><BR>                                 <td align="left" valign="top" colspan="6" styleCode="Lrule Botrule Rrule">(1) Cox regression model with the following covariates: ECOG performance status, number of prior regimens, prior platinum, best response to prior chemotherapy.<br/>(2) Two-sided Log-Rank test stratified by ECOG performance status, number of prior regimens, prior platinum, best response to prior chemotherapy.<br/>(3) Two-sided Fisher&#8217;s exact test</td><BR>                              </tr><BR>                           </tfoot><BR>                           <tbody><BR>                              <tr ID="id_a3532c3e-0342-43fd-90e6-21aa6e18e2b4"><BR>                                 <td align="left" valign="bottom" styleCode="Botrule Toprule Rrule Lrule"/><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold"> TARCEVA</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Placebo</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Hazard<br/>Ratio (1)</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">95%&#160;CI</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">p-value</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_365a150b-0069-465f-ba33-93d874228bdf"><BR>                                 <td align="left" valign="bottom" styleCode="Lrule Botrule Rrule">Survival</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <paragraph> Median</paragraph>6.7 mo</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <paragraph>Median</paragraph>4.7 mo</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule">0.73</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule">0.61 &#8211; 0.86</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule">&lt;0.001 (2)</td><BR>                              </tr><BR>                              <tr ID="id_967f0e90-9b27-49d6-afe4-f900dd623666"><BR>                                 <td align="left" valign="bottom" styleCode="Lrule Botrule Rrule">1-year Survival</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule">31.2%</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule">21.5%</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_58f15319-f61c-4195-b57e-cf318e74cb3e"><BR>                                 <td align="left" valign="bottom" styleCode="Lrule Botrule Rrule">Progression-Free Survival</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <paragraph> Median</paragraph>9.9 wk</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <paragraph>Median</paragraph>7.9 wk</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule">0.59</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule">0.50 &#8211; 0.70</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule">&lt;0.001 (2)</td><BR>                              </tr><BR>                              <tr ID="id_d89022d5-0e9a-4c08-88b7-db5506e90c78"><BR>                                 <td align="left" valign="bottom" styleCode="Lrule Botrule Rrule">Tumor Response (CR+PR)</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule">8.9%</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule">0.9%</td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule">&lt;0.001 (3)</td><BR>                              </tr><BR>                              <tr ID="id_ea657d14-d44f-469a-89be-240d72edfa91"><BR>                                 <td align="left" valign="bottom" styleCode="Lrule Botrule Rrule">Response Duration</td><BR>                                 <td align="center" valign="bottom" styleCode="Rrule">Median<br/>34.3 wk</td><BR>                                 <td align="center" valign="bottom" styleCode="Rrule"><BR>                                    <paragraph>Median</paragraph>15.9 wk</td><BR>                                 <td align="center" valign="bottom" styleCode="Rrule"/><BR>                                 <td align="center" valign="bottom" styleCode="Rrule"/><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>Survival was evaluated in the intent-to-treat population. Figure 2 depicts the Kaplan-Meier curves for overall survival. The primary survival and PFS analyses were two-sided Log-Rank tests stratified by ECOG performance status, number of prior regimens, prior platinum, best response to prior chemotherapy.<BR>                        <BR>                        <BR>                           Note: HR is from Cox regression model with the following covariates: ECOG performance status, number of prior regimens, prior platinum, best response to prior chemotherapy. P-value is from two-sided Log-Rank test stratified by ECOG performance status, number of prior regimens, prior platinum, best response to prior chemotherapy.<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     14.3 NSCLC - TARCEVA Administered Concurrently with Chemotherapy<BR>                     <BR>                        Results from two, multicenter, placebo-controlled, randomized, trials in over 1000 patients conducted in first-line patients with locally advanced or metastatic NSCLC showed no clinical benefit with the concurrent administration of TARCEVA with platinum-based chemotherapy [carboplatin and paclitaxel (TARCEVA, N = 526) or gemcitabine and cisplatin (TARCEVA, N = 580)].<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     14.4 Pancreatic Cancer - TARCEVA Administered Concurrently with Gemcitabine<BR>                     <BR>                        The efficacy and safety of TARCEVA in combination with gemcitabine as a first-line treatment was assessed in a randomized, double blind, placebo-controlled trial in 569 patients with locally advanced, unresectable or metastatic pancreatic cancer. Patients were randomized 1:1 to receive TARCEVA (100 mg or 150 mg) or placebo once daily on a continuous schedule plus gemcitabine IV (1000 mg/m2, Cycle 1 - Days 1, 8, 15, 22, 29, 36 and 43 of an 8 week cycle; Cycle 2 and subsequent cycles - Days 1, 8 and 15 of a 4 week cycle [the approved dose and schedule for pancreatic cancer, see the gemcitabine package insert]). TARCEVA or placebo was taken orally once daily until disease progression or unacceptable toxicity. The primary endpoint was survival. Secondary endpoints included response rate, and progression-free survival (PFS). Duration of response was also examined. The study was conducted in 18 countries. A total of 285 patients were randomized to receive gemcitabine plus TARCEVA (261 patients in the 100 mg cohort and 24 patients in the 150 mg cohort) and 284 patients were randomized to receive gemcitabine plus placebo (260 patients in the 100 mg cohort and 24 patients in the 150 mg cohort). Too few patients were treated in the 150 mg cohort to draw conclusions.<BR>                        <BR>                           Table 9 summarizes the demographic and disease characteristics of the study population that was randomized to receive 100 mg of TARCEVA plus gemcitabine or placebo plus gemcitabine. Baseline demographic and disease characteristics of the patients were similar between the 2 treatment groups, except for a slightly larger proportion of females in the TARCEVA arm (51%) compared with the placebo arm (44%). The median time from initial diagnosis to randomization was approximately 1.0 month. Most patients presented with metastatic disease at study entry as the initial manifestation of pancreatic cancer.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="single" width="284.000" ID="id_bf38034e-2468-4dd3-a827-7e81f71b517e"><BR>                           <caption ID="id_e780bff0-c838-4a80-9c94-82e4eb754d37">Table 9: Demographic and Disease Characteristics: 100 mg Cohort</caption><BR>                           <col width="39.4%"/><BR>                           <col width="13.0%"/><BR>                           <col width="16.2%"/><BR>                           <col width="15.5%"/><BR>                           <col width="15.8%"/><BR>                           <tfoot ID="id_40d7fe41-480e-4cc7-a6ec-2399b2df6074"><BR>                              <tr><BR>                                 <td align="left" valign="top" colspan="5" styleCode="Lrule Botrule Rrule">*Unknown includes responses of 'Unknown' and missing.<br/>**Stratification factor as documented at baseline; distribution differs slightly from values reported at time of randomization.</td><BR>                              </tr><BR>                           </tfoot><BR>                           <tbody><BR>                              <tr ID="id_115be3d7-9829-4acb-997f-8b9e4af20d4b"><BR>                                 <td align="left" valign="bottom" styleCode="Botrule Toprule Rrule Lrule"/><BR>                                 <td align="center" valign="bottom" colspan="2" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">TARCEVA+ Gemcitabine<br/><BR>                                       <br/>(N=261)</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" colspan="2" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Placebo + Gemcitabine <br/><BR>                                       <br/>(N=260)</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_59a20f5b-6bfa-47cf-ad74-b5fb331576bb"><BR>                                 <td align="left" valign="bottom" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Characteristics</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">N</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">(%)</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">N </content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">(%)</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_f985ca12-7b47-450c-a144-762c6bfbee7c"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Gender</content><BR>                                 </td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_9545a997-cab5-4bc8-821e-99a3c894a1c3"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Female</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">134</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(51)</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">114</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(44)</td><BR>                              </tr><BR>                              <tr ID="id_27720846-27bc-44e5-b12e-5f517b432d7f"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Male</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">127</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(49)</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">146</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(56)</td><BR>                              </tr><BR>                              <tr ID="id_9d31d306-189c-4645-9760-11495b217f6f"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Age (Years)</content><BR>                                 </td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_64ad0e27-8fc1-42f6-85fc-cb3cdaa28991"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;&lt;65</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">136</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(52)</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">138</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(53)</td><BR>                              </tr><BR>                              <tr ID="id_d739289a-2789-45d9-84c9-4c8dbbeb6658"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;&#8805;65</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">125</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(48)</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">122</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(47)</td><BR>                              </tr><BR>                              <tr ID="id_e64e0a46-fbb2-48ed-a0b1-059e365c2bfa"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Race</content><BR>                                 </td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_2876ec20-3844-4efc-a01c-c02242d5aee9"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Caucasian</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">225</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(86)</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">231</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(89)</td><BR>                              </tr><BR>                              <tr ID="id_c73e5ddd-da0c-42fb-9660-99a3b34bf4c8"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Black</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">8</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(3)</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">5</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(2)</td><BR>                              </tr><BR>                              <tr ID="id_a026d7a7-e3a8-475a-991d-b6e45bef816d"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Asian</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">20</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(8)</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">14</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(5)</td><BR>                              </tr><BR>                              <tr ID="id_90dc8180-42eb-465d-8754-d868a0b6a286"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Other</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">8</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(3)</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">10</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(3)</td><BR>                              </tr><BR>                              <tr ID="id_476739b3-eb03-40e2-bacc-c1f176581765"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">ECOG Performance Status*</content><BR>                                 </td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_a9eec818-4261-4591-82a7-733aa2b89ed7"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;0</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">82</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(31)</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">83</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(32)</td><BR>                              </tr><BR>                              <tr ID="id_f77f7e2d-a0da-4c20-a811-61decc204eb1"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;1</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">134</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(51)</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">132</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(51)</td><BR>                              </tr><BR>                              <tr ID="id_6a42f898-07a9-4d89-8e8e-b134ee09e268"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;2</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">44</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(17)</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">45</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(17)</td><BR>                              </tr><BR>                              <tr ID="id_c98f39c4-dc15-4918-909c-9346ec5d1b9c"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Unknown*</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">1</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(&lt;1)</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(0)</td><BR>                              </tr><BR>                              <tr ID="id_320807cf-2cc6-43dd-89da-a55c2e7f19be"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">Disease Status at Baseline**</content><BR>                                 </td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_6cc84654-266c-416a-b4ba-e1265b358c75"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"> Locally Advanced</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">61</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(23)</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">63</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(24)</td><BR>                              </tr><BR>                              <tr ID="id_8038258d-ca38-4942-9142-c449c2bbf9bf"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">&#160;&#160;&#160;&#160;&#160;Distant Metastasis</td><BR>                                 <td align="right" valign="top" styleCode="Rrule">200</td><BR>                                 <td align="right" valign="top" styleCode="Rrule">(77)</td><BR>                                 <td align="right" valign="top" styleCode="Rrule">197</td><BR>                                 <td align="right" valign="top" styleCode="Botrule Rrule">(76)</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>The results of the study are shown in Table 10.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="single" width="422.000" ID="id_4899fd4d-2a03-4566-8fd9-06927eaeb724"><BR>                           <caption ID="id_815ff8ae-2d32-49f8-855e-aef5562a20a7">Table 10: Efficacy Results: 100 mg Cohort</caption><BR>                           <col width="16.8%"/><BR>                           <col width="18.2%"/><BR>                           <col width="18.2%"/><BR>                           <col width="14.2%"/><BR>                           <col width="15.6%"/><BR>                           <col width="16.8%"/><BR>                           <tfoot ID="id_cbdca10b-d86b-4e50-baa1-cc6fbe5df45f"><BR>                              <tr><BR>                                 <td align="left" valign="top" colspan="6" styleCode="Lrule Botrule Rrule">(1) Cox regression model with the following covariates: ECOG performance status, and extent of disease.<br/>(2) Two-sided Log-Rank test stratified by ECOG performance status and extent of disease.<br/>(3) Two-sided Fisher&#8217;s exact test.</td><BR>                              </tr><BR>                           </tfoot><BR>                           <tbody><BR>                              <tr ID="id_4260907a-f03b-4f07-acef-8f53e872d655"><BR>                                 <td align="left" valign="top" styleCode="Botrule Toprule Rrule Lrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule"><BR>                                    <content styleCode="bold">TARCEVA + Gemcitabine</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"><BR>                                    <content styleCode="bold">Placebo+ Gemcitabine</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"><BR>                                    <content styleCode="bold">Hazard<br/>Ratio (1)</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"><BR>                                    <content styleCode="bold">95%&#160;CI</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">p-value</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_49b56dc4-0034-41f3-97f2-4e3ed1e57ba5"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Survival</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <paragraph>Median</paragraph><BR>                                    <paragraph>6.4 mo</paragraph>250 deaths</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <paragraph>Median</paragraph><BR>                                    <paragraph>6.0 mo</paragraph>254 deaths</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.81</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.68 &#8211; 0.97</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.028 (2)</td><BR>                              </tr><BR>                              <tr ID="id_5fe15c49-159d-4f07-a04f-7bd0ccfdb851"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">1-year Survival</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">23.8%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">19.4%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                              <tr ID="id_283ee9ee-f1df-4dc0-bc34-9dcd9a015b68"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Progression-Free Survival</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <paragraph>Median</paragraph><BR>                                    <paragraph>3.8 mo</paragraph>225 events</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <paragraph>Median</paragraph><BR>                                    <paragraph>3.5 mo</paragraph>232 events</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.76</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.64 &#8211; 0.92</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.006 (2)</td><BR>                              </tr><BR>                              <tr ID="id_038b5135-33ab-449c-bc25-c0a6d76c435d"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Tumor Response (CR+PR)</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.6%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">7.9%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.87 (3)</td><BR>                              </tr><BR>                              <tr ID="id_5482caa0-8f7a-4ba3-80dc-3b2ba97aa6ff"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Response Duration</td><BR>                                 <td align="center" valign="top" styleCode="Rrule"><BR>                                    <paragraph>Median</paragraph>23.9 wk</td><BR>                                 <td align="center" valign="top" styleCode="Rrule"><BR>                                    <paragraph>Median</paragraph>23.3 wk</td><BR>                                 <td align="center" valign="top" styleCode="Rrule"/><BR>                                 <td align="center" valign="top" styleCode="Rrule"/><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"/><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>Survival was evaluated in the intent-to-treat population. Figure 3 depicts the Kaplan-Meier curves for overall survival in the 100 mg cohort. The primary survival and PFS analyses were two-sided Log-Rank tests stratified by ECOG performance status and extent of disease.<BR>                        <BR>                        <BR>                           Note: HR is from Cox regression model with the following covariates: ECOG performance status and extent of disease. P-value is from two-sided Log-Rank test stratified by ECOG performance status and extent of disease.<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     Kaplan-Meier Curve for Overall Survival of Patients by Treatment Group<BR>                     <BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     Kaplan-Meier Curve for Overall Survival of Patients by Treatment Group<BR>                     <BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     Kaplan-Meier Curve for Overall Survival: 100 mg Cohort<BR>                     <BR>                        <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>